Cargando…

Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodies

BACKGROUND: Lysosomal dysfunction is thought to be a prominent feature in the pathogenetic events leading to Parkinson’s disease (PD). This view is supported by the evidence that mutations in GBA gene, coding the lysosomal hydrolase β-glucocerebrosidase (GCase), are a common genetic risk factor for...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiasserini, Davide, Paciotti, Silvia, Eusebi, Paolo, Persichetti, Emanuele, Tasegian, Anna, Kurzawa-Akanbi, Marzena, Chinnery, Patrick F, Morris, Christopher M, Calabresi, Paolo, Parnetti, Lucilla, Beccari, Tommaso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4428238/
https://www.ncbi.nlm.nih.gov/pubmed/25881142
http://dx.doi.org/10.1186/s13024-015-0010-2
_version_ 1782370860665929728
author Chiasserini, Davide
Paciotti, Silvia
Eusebi, Paolo
Persichetti, Emanuele
Tasegian, Anna
Kurzawa-Akanbi, Marzena
Chinnery, Patrick F
Morris, Christopher M
Calabresi, Paolo
Parnetti, Lucilla
Beccari, Tommaso
author_facet Chiasserini, Davide
Paciotti, Silvia
Eusebi, Paolo
Persichetti, Emanuele
Tasegian, Anna
Kurzawa-Akanbi, Marzena
Chinnery, Patrick F
Morris, Christopher M
Calabresi, Paolo
Parnetti, Lucilla
Beccari, Tommaso
author_sort Chiasserini, Davide
collection PubMed
description BACKGROUND: Lysosomal dysfunction is thought to be a prominent feature in the pathogenetic events leading to Parkinson’s disease (PD). This view is supported by the evidence that mutations in GBA gene, coding the lysosomal hydrolase β-glucocerebrosidase (GCase), are a common genetic risk factor for PD. Recently, GCase activity has been shown to be decreased in substantia nigra and in cerebrospinal fluid of patients diagnosed with PD or dementia with Lewy Bodies (DLB). Here we measured the activity of GCase and other endo-lysosomal enzymes in different brain regions (frontal cortex, caudate, hippocampus, substantia nigra, cerebellum) from PD (n = 26), DLB (n = 16) and age-matched control (n = 13) subjects, screened for GBA mutations. The relative changes in GCase gene expression in substantia nigra were also quantified by real-time PCR. The role of potential confounders (age, sex and post-mortem delay) was also determined. FINDINGS: Substantia nigra showed a high activity level for almost all the lysosomal enzymes assessed. GCase activity was significantly decreased in the caudate (−23%) and substantia nigra (−12%) of the PD group; the same trend was observed in DLB. In both groups, a decrease in GCase mRNA was documented in substantia nigra. No other lysosomal hydrolase defects were determined. CONCLUSION: The high level of lysosomal enzymes activity observed in substantia nigra, together with the selective reduction of GCase in PD and DLB patients, further support the link between lysosomal dysfunction and PD pathogenesis, favoring the possible role of GCase as biomarker of synucleinopathy. Mapping the lysosomal enzyme activities across different brain areas can further contribute to the understanding of the role of lysosomal derangement in PD and other synucleinopathies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13024-015-0010-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4428238
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44282382015-05-13 Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodies Chiasserini, Davide Paciotti, Silvia Eusebi, Paolo Persichetti, Emanuele Tasegian, Anna Kurzawa-Akanbi, Marzena Chinnery, Patrick F Morris, Christopher M Calabresi, Paolo Parnetti, Lucilla Beccari, Tommaso Mol Neurodegener Short Report BACKGROUND: Lysosomal dysfunction is thought to be a prominent feature in the pathogenetic events leading to Parkinson’s disease (PD). This view is supported by the evidence that mutations in GBA gene, coding the lysosomal hydrolase β-glucocerebrosidase (GCase), are a common genetic risk factor for PD. Recently, GCase activity has been shown to be decreased in substantia nigra and in cerebrospinal fluid of patients diagnosed with PD or dementia with Lewy Bodies (DLB). Here we measured the activity of GCase and other endo-lysosomal enzymes in different brain regions (frontal cortex, caudate, hippocampus, substantia nigra, cerebellum) from PD (n = 26), DLB (n = 16) and age-matched control (n = 13) subjects, screened for GBA mutations. The relative changes in GCase gene expression in substantia nigra were also quantified by real-time PCR. The role of potential confounders (age, sex and post-mortem delay) was also determined. FINDINGS: Substantia nigra showed a high activity level for almost all the lysosomal enzymes assessed. GCase activity was significantly decreased in the caudate (−23%) and substantia nigra (−12%) of the PD group; the same trend was observed in DLB. In both groups, a decrease in GCase mRNA was documented in substantia nigra. No other lysosomal hydrolase defects were determined. CONCLUSION: The high level of lysosomal enzymes activity observed in substantia nigra, together with the selective reduction of GCase in PD and DLB patients, further support the link between lysosomal dysfunction and PD pathogenesis, favoring the possible role of GCase as biomarker of synucleinopathy. Mapping the lysosomal enzyme activities across different brain areas can further contribute to the understanding of the role of lysosomal derangement in PD and other synucleinopathies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13024-015-0010-2) contains supplementary material, which is available to authorized users. BioMed Central 2015-03-27 /pmc/articles/PMC4428238/ /pubmed/25881142 http://dx.doi.org/10.1186/s13024-015-0010-2 Text en © Chiasserini et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Short Report
Chiasserini, Davide
Paciotti, Silvia
Eusebi, Paolo
Persichetti, Emanuele
Tasegian, Anna
Kurzawa-Akanbi, Marzena
Chinnery, Patrick F
Morris, Christopher M
Calabresi, Paolo
Parnetti, Lucilla
Beccari, Tommaso
Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodies
title Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodies
title_full Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodies
title_fullStr Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodies
title_full_unstemmed Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodies
title_short Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodies
title_sort selective loss of glucocerebrosidase activity in sporadic parkinson’s disease and dementia with lewy bodies
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4428238/
https://www.ncbi.nlm.nih.gov/pubmed/25881142
http://dx.doi.org/10.1186/s13024-015-0010-2
work_keys_str_mv AT chiasserinidavide selectivelossofglucocerebrosidaseactivityinsporadicparkinsonsdiseaseanddementiawithlewybodies
AT paciottisilvia selectivelossofglucocerebrosidaseactivityinsporadicparkinsonsdiseaseanddementiawithlewybodies
AT eusebipaolo selectivelossofglucocerebrosidaseactivityinsporadicparkinsonsdiseaseanddementiawithlewybodies
AT persichettiemanuele selectivelossofglucocerebrosidaseactivityinsporadicparkinsonsdiseaseanddementiawithlewybodies
AT tasegiananna selectivelossofglucocerebrosidaseactivityinsporadicparkinsonsdiseaseanddementiawithlewybodies
AT kurzawaakanbimarzena selectivelossofglucocerebrosidaseactivityinsporadicparkinsonsdiseaseanddementiawithlewybodies
AT chinnerypatrickf selectivelossofglucocerebrosidaseactivityinsporadicparkinsonsdiseaseanddementiawithlewybodies
AT morrischristopherm selectivelossofglucocerebrosidaseactivityinsporadicparkinsonsdiseaseanddementiawithlewybodies
AT calabresipaolo selectivelossofglucocerebrosidaseactivityinsporadicparkinsonsdiseaseanddementiawithlewybodies
AT parnettilucilla selectivelossofglucocerebrosidaseactivityinsporadicparkinsonsdiseaseanddementiawithlewybodies
AT beccaritommaso selectivelossofglucocerebrosidaseactivityinsporadicparkinsonsdiseaseanddementiawithlewybodies